1-13 of 13
Authors: Balint Otvos
Journal Article
IMMU-34. SYSTEMIC IMMUNE SUPPRESSION IN GLIOBLASTOMA IS TARGETED BY CONCURRENT VEGF AND PD-1 INHIBITION IN A DOSE-DEPENDENT MANNER: TRANSCRIPTOMIC FINDINGS THROUGH CITE-SEQ FROM A RANDOMIZED CONTROLLED TRIAL Free
Neuro-Oncology, Volume 25, Issue Supplement_5, November 2023, Page v149, https://doi.org/10.1093/neuonc/noad179.0566
Published: 10 November 2023
Journal Article
SURG-03. COMBINATION LASER INTERSTITIAL THERMAL THERAPY PLUS SRS INCREASES TIME TO PROGRESSION FOR RECURRENT SRS-TREATED BRAIN METASTASES Free
Neuro-Oncology, Volume 22, Issue Supplement_2, November 2020, Page ii203, https://doi.org/10.1093/neuonc/noaa215.850
Published: 09 November 2020
Journal Article
IMMU-10. GENOMIC DIFFERENCES UNDERLIE MYELOID-DERIVED SUPPRESSOR CELL SEXUAL DIMORPHISM IN GLIOBLASTOMA Free
Neuro-Oncology, Volume 22, Issue Supplement_2, November 2020, Pages ii106–ii107, https://doi.org/10.1093/neuonc/noaa215.441
Published: 09 November 2020
Journal Article
INNV-02. RADIOGRAPHIC CHARACTERISTICS AND STEROID USAGE IN LASER INTERSTITIAL THERMAL THERAPY VERSUS MEDICAL MANAGEMENT FOR BIOPSY-PROVEN RADIATION NECROSIS AFTER STEREOTACTIC RADIOSURGERY OF BRAIN METASTASES Free
Neuro-Oncology, Volume 22, Issue Supplement_2, November 2020, Pages ii116–ii117, https://doi.org/10.1093/neuonc/noaa215.486
Published: 09 November 2020
Journal Article
IMMU-08. MODELING UPFRONT GLIOBLASTOMA SURGICAL RESECTION AND STEROID USE REVEALS IMMUNOSUPPRESSIVE CHANGES AND SUGGESTS THAT PERIPHERAL LYMPHOCYTE COUNTS ARE ASSOCIATED WITH TUMOR VOLUME AND PROGNOSIS Free
Neuro-Oncology, Volume 22, Issue Supplement_2, November 2020, Page ii106, https://doi.org/10.1093/neuonc/noaa215.439
Published: 09 November 2020
Journal Article
GENE-26. HOST GENETIC VARIATIONS IN MACROPHAGE MIGRATION INHIBITOR FACTOR CONFER WORSE PROGNOSIS IN GLIOBLASTOMA Free
Neuro-Oncology, Volume 21, Issue Supplement_6, November 2019, Page vi103, https://doi.org/10.1093/neuonc/noz175.428
Published: 11 November 2019
Journal Article
IMMU-28. TARGETING IMMUNOSUPPRESSIVE MYELOID DERIVED SUPPRESSOR CELLS VIA MIF/CD74 SIGNALING AXIS TO ATTENUATE GBM GROWTH Free
Neuro-Oncology, Volume 21, Issue Supplement_6, November 2019, Page vi125, https://doi.org/10.1093/neuonc/noz175.521
Published: 11 November 2019
Journal Article
ATIM-40. CIRCULATING MYELOID-DERIVED SUPPRESSOR CELLS PREDICT FAVORABLE RESPONSE TO IMMUNE CHECKPOINT THERAPY IN A RANDOMIZED TRIAL OF NIVOLUMAB AND BEVACIZUMAB IN RECURRENT GBM Free
Neuro-Oncology, Volume 21, Issue Supplement_6, November 2019, Page vi10, https://doi.org/10.1093/neuonc/noz175.039
Published: 11 November 2019
Journal Article
Coordination of self-renewal in glioblastoma by integration of adhesion and microRNA signaling Free
Neuro-Oncology, Volume 18, Issue 5, May 2016, Pages 656–666, https://doi.org/10.1093/neuonc/nov196
Published: 15 September 2015
Journal Article
Development of a Sox2 reporter system modeling cellular heterogeneity in glioma Get access
Neuro-Oncology, Volume 17, Issue 3, March 2015, Pages 361–371, https://doi.org/10.1093/neuonc/nou320
Published: 21 November 2014
Journal Article
ME-15INTERACTION BETWEEN CANCER STEM CELLS AND MYELOID DERIVED SUPPRESSOR CELLS DRIVES IMMUNOSUPPRESSION AND GLIOBLASTOMA GROWTH Get access
Neuro-Oncology, Volume 16, Issue suppl_5, November 2014, Page v123, https://doi.org/10.1093/neuonc/nou261.14
Published: 01 November 2014
Journal Article
SC-11DIFFERENTIAL CONNEXIN FUNCTION ENHANCES SELF-RENEWAL IN GLIOBLASTOMA Get access
Neuro-Oncology, Volume 16, Issue suppl_5, November 2014, Page v199, https://doi.org/10.1093/neuonc/nou275.11
Published: 01 November 2014
Journal Article
THE ROLE OF MYELOID DERIVED SUPPRESSOR CELLS (MDSCS) IN TUMOR-INDUCED IMMUNOSUPPRESSION IN HUMAN AND MURINE GLIOMAS Get access
Neuro-Oncology, Volume 16, Issue suppl_3, July 2014, Page iii44, https://doi.org/10.1093/neuonc/nou209.10
Published: 01 July 2014
